A detailed history of Pinnacle Financial Partners Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 48,279 shares of BMY stock, worth $1.93 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
48,279
Previous 48,911 1.29%
Holding current value
$1.93 Million
Previous $2.51 Million 4.34%
% of portfolio
0.06%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$47.98 - $54.4 $30,323 - $34,380
-632 Reduced 1.29%
48,279 $2.62 Million
Q4 2023

Jan 22, 2024

SELL
$48.48 - $57.85 $11,004 - $13,131
-227 Reduced 0.46%
48,911 $2.51 Million
Q3 2023

Nov 03, 2023

SELL
$57.89 - $64.73 $270,404 - $302,353
-4,671 Reduced 8.68%
49,138 $2.85 Million
Q2 2023

Aug 07, 2023

SELL
$63.71 - $70.74 $64,283 - $71,376
-1,009 Reduced 1.84%
53,809 $3.44 Million
Q1 2023

Apr 26, 2023

BUY
$65.71 - $74.53 $251,209 - $284,928
3,823 Added 7.5%
54,818 $3.8 Million
Q4 2022

Feb 03, 2023

SELL
$68.48 - $81.09 $366,436 - $433,912
-5,351 Reduced 9.5%
50,995 $3.67 Million
Q3 2022

Oct 31, 2022

BUY
$0.13 - $76.84 $167 - $98,816
1,286 Added 2.34%
56,346 $4.01 Million
Q2 2022

Jul 29, 2022

BUY
$72.62 - $79.98 $637,530 - $702,144
8,779 Added 18.97%
55,060 $4.24 Million
Q1 2022

May 02, 2022

SELL
$61.48 - $73.72 $33,322 - $39,956
-542 Reduced 1.16%
46,281 $3.38 Million
Q4 2021

Feb 01, 2022

BUY
$53.63 - $62.52 $155,473 - $181,245
2,899 Added 6.6%
46,823 $2.92 Million
Q3 2021

Oct 26, 2021

SELL
$59.17 - $69.31 $101,713 - $119,143
-1,719 Reduced 3.77%
43,924 $2.6 Million
Q2 2021

Jul 21, 2021

BUY
$61.91 - $67.42 $243,244 - $264,893
3,929 Added 9.42%
45,643 $3.05 Million
Q1 2021

Apr 19, 2021

SELL
$59.34 - $66.74 $213,802 - $240,464
-3,603 Reduced 7.95%
41,714 $2.63 Million
Q4 2020

Jan 13, 2021

BUY
$57.74 - $65.43 $17,033 - $19,301
295 Added 0.66%
45,317 $2.81 Million
Q3 2020

Oct 27, 2020

SELL
$57.43 - $63.64 $253,668 - $281,097
-4,417 Reduced 8.93%
45,022 $2.72 Million
Q2 2020

Jul 28, 2020

SELL
$54.82 - $64.09 $50,653 - $59,219
-924 Reduced 1.83%
49,439 $2.91 Million
Q1 2020

Apr 16, 2020

SELL
$46.4 - $67.43 $54,520 - $79,230
-1,175 Reduced 2.28%
50,363 $2.81 Million
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $101,224 - $132,038
2,057 Added 4.16%
51,538 $3.31 Million
Q3 2019

Oct 25, 2019

BUY
$42.77 - $50.71 $199,607 - $236,663
4,667 Added 10.41%
49,481 $2.51 Million
Q2 2019

Aug 13, 2019

BUY
$44.62 - $49.34 $99,056 - $109,534
2,220 Added 5.21%
44,814 $2.03 Million
Q1 2019

May 02, 2019

SELL
$45.12 - $53.8 $54,865 - $65,420
-1,216 Reduced 2.78%
42,594 $2.03 Million
Q4 2018

Feb 04, 2019

SELL
$48.76 - $63.23 $99,421 - $128,925
-2,039 Reduced 4.45%
43,810 $2.28 Million
Q3 2018

Oct 31, 2018

BUY
$55.19 - $62.25 $10,762 - $12,138
195 Added 0.43%
45,849 $2.85 Million
Q2 2018

Jul 27, 2018

BUY
$50.53 - $62.98 $186,354 - $232,270
3,688 Added 8.79%
45,654 $2.53 Million
Q1 2018

May 03, 2018

SELL
$59.92 - $68.98 $18,035 - $20,762
-301 Reduced 0.71%
41,966 $2.65 Million
Q4 2017

Feb 08, 2018

SELL
$59.94 - $65.35 $63,896 - $69,663
-1,066 Reduced 2.46%
42,267 $2.59 Million
Q3 2017

Nov 08, 2017

BUY
$55.23 - $63.74 $2.39 Million - $2.76 Million
43,333
43,333 $2.76 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85.2B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pinnacle Financial Partners Inc Portfolio

Follow Pinnacle Financial Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.